Internalization of indium-labeled LDL through a lipid chelating anchor in human pancreatic-cancer cells as a potential radiopharmaceutical for tumor localization

International Journal of Cancer

Volumn 70, Issue 3, 1997, Pages 315-322

  Urizzi, Pascale ^a   Souchard, Jean Pierre ^a   Palevody, Claude ^a   Ratovo, Ginette ^a   Hollande, Etienne ^a   Nepveu, Françoise ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM 111; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN INDIUM 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG BINDING; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR LOCALIZATION;

CARBOCYANINES; FLUORESCENT DYES; HUMANS; INDIUM RADIOISOTOPES; LIPOPROTEINS, LDL; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; TUMOR CELLS, CULTURED;

EID: 0031038761     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970127)70:3<315::AID-IJC12>3.0.CO;2-E     Document Type: Article

References (20)

1. BROWN, M.S. and GOLDSTEIN, J.L., A receptor-mediated pathway for cholesterol homeostasis. Angew. Chem., 25, 583-602 (1986).
2. FÖGH, J., FÖGH, J.M. and ORFEO. T., One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. nat. Cancer Inst., 59, 221-226 (1977).
3. FRENS, G., Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature Phys. Sci., 241, 20-22 (1973).
4. GAL, D., SIMPSON, E.R., PORTER, J.C. and SNYDER, J.M., Defective internalization of low-density lipoprotein in epidermoid cervical-cancer cells. J. Cell Biol., 92, 597-603 (1982).
5. GUEDDARI, N., FAVRE, G., HACHEM, H., MAREK, E., LE GAILLARD, F. and SOULA, G., Evidence for up-regulated low-density lipoprotein receptor in human lung-adenocarcinoma cell line A549. Biochimie, 75, 811-819 (1993).
6. HANTLEY, D.A., ARBEENY, C.M., WITTE, L.D. and CHIEN, S., Colloidal gold-low-density-lipoprotein conjugates as membrane receptor probes. Proc. nat. Acad. Sci. (Wash.), 78, 368-371 (1981).
7. HAVEKES, L., VAN HINSBERGH, V., KEMPEN, H.J. and EMEIS, J., The metabolism in vitro of human low-density lipoproteins by the human hepatoma cell line Hep G2. Biochem. J., 214, 951-958 (1983).
8. HO, Y.K., SMITH, R.G., BROWN, M.S. and GOLDSTEIN, J.L., Low-density-lipoprotein (LDL)-receptor activity in human acute-myelogenous-leukemia cells. Blood, 52, 1099-1114 (1978).
9. HYNDS, S.A., WELSH, J., STEWART, J.M., JACK, A., SOUKOP, M., MCARDLE, C.S., CALMAN, K.C., PACKARD, C.J. and SHEPHERD, J., Low-density-lipoprotein metabolism in mice with soft-tissue tumours. Biochim. biophys. Acta, 795, 589-595 (1984).
10. JASANADA, F., URIZZI, P., SOUCHARD, J.-P, LE GAILLARD, F., FAVRE, G. and NEPVEU, F., Indium-111 labeling of low-density lipoprotein with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. Bioconjugate Chem., 7, 72-81 (1996).
11. LEE, H.S. and KOH, H.I., Visualization of binding and uptake of oxidized low-density lipoproteins by cultured mesangial cells. Lab. Invest., 71, 200-208 (1994).
12. LOMBARDI, P., NORATA, G., MAGGI, F.M., CANTI, G., FRANCO, P., NICOLIN, A. and CATAPANO, A.L., Assimilation of LDL by experimental tumours in mice. Biochim. biophys. Acta, 1003, 301-306 (1989).
13. PONTY, E., FAVRE, G., BENANIBA, R., BONEU, A., LUCOT, H., CARTON, M. and SOULA, G., Biodistribution study of 99mTc-labeled LDL in Biomelanoma-bearing mice. Visualization of a preferential uptake by the tumor. Int. J. Cancer, 54, 1-7 (1993).
14. ROSEN, J.M., BUTLER, S.P., MEINKEN, G.E., WANG, T.S.T., RAMAKRISHNAN, R., SRIVASTAVA, S.C., ALDERSON, P.O. and GINSBERG, H.N., Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. J. nucl. Med., 31, 343-350 (1990).
15. RUDLING, M.J., REIHNER, E., EINARSSON, K., EWERTH, S. and ANGELIN, B., Low-density-lipoprotein-receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc. nat. Acad. Sci. (Wash.), 87, 3469-3473 (1990).
16. SAMADI-BABOLI, M., FAVRE, G., CANAL, P. and SOULA, G., Low-density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice. Brit. J. Cancer, 68, 319-326 (1993).
17. STEPHAN, Z.F. and YURACHEK, E.C., Rapid fluorometric assay of LDL-receptor activity by Dil-labeled LDL. J. Lipid Res., 34, 325-330 (1993).
18. VIRGOLINI, I., ANGELBERGER, P., LI, S.R., KOLLER, F., KOLLER, E., PIDLICH, J., LUPATTELLI, G. and SINZINGER, H., Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoprotein. J. nucl. Med., 32, 2132-2138 (1991).
19. WADE, D.P., KNIGHT, B.L. and SOUTAR, A.K., Hormonal regulation of low-density-lipoprotein (LDL)-receptor activity in human hepatoma Hep G2 cells. Insulin increases LDL-receptor activity and diminishes its suppression by exogenous LDL. Europ. J. Biochem., 174, 213-218 (1988).
20. WARSHAW, A.L. and FERNANDEZ DEL CASTILLO, C., Medical progress - pancreatic carcinoma. New Engl. J. Med., 326, 455-465 (1992).